Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 93-99

  Andersson, K E ^a   Svedberg, K A ^a   Lindholm, M W ^b   Oste R ^c   Hellstrand, P ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Cholesterol; Diet; ENOS; Inflammation; Lipids; Lipoproteins; Oats

Indexed keywords

BILE ACID; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SERUM AMYLOID A; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BILE ACID BLOOD LEVEL; BRAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DESCENDING AORTA; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFECT; FECES; FEMALE; FIBRINOGEN BLOOD LEVEL; IMMUNOFLUORESCENCE; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; OAT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; AVENA SATIVA; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; BODY WEIGHT; CHOLESTEROL; DIETARY FIBER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; FECES; FEMALE; FIBRINOGEN; HYPOLIPIDEMIC AGENTS; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, LDL; TIME FACTORS; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77956229175     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.001     Document Type: Article

References (31)

1. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
2. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
3. Getz G.S., Reardon C.A. Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol 2007, 27:2499-2506.
4. Kerckhoffs D.A., Brouns F., Hornstra G., Mensink R.P. Effects on the human serum lipoprotein profile of beta-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 2002, 132:2494-2505.
5. Brennan C.S., Cleary L.J. Review: the potential use of cereal (1/3,1/4)-β-d-glucans as functional food ingredients. J Cereal Sci 2005, 42:1-13.
6. Kelly S.A., Summerbell C.D., Brynes A., Whittaker V., Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev 2007, CD005051.
7. Peterson D. Oat antioxidants. J Cereal Sci 2001, 33:115-129.
8. Liu L., Zubik L., Collins F.W., Marko M., Meydani M. The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 2004, 175:39-49.
9. Nie L., Wise M.L., Peterson D.M., Meydani M. Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production. Atherosclerosis 2006, 186:260-266.
10. Wilson T.A., Idreis H.M., Taylor C.M., Nicolosi R.J. Whole fat rice bran reduces the development of early aortic atherosclerosis in hypercholesterolemic hamsters compared with wheat bran. Nutr Res 2002, 22:1319-1322.
11. Delaney B., Nicolosi R.J., Wilson T.A., et al. Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J Nutr 2003, 133:468-475.
12. Andersson K.E., Immerstrand T., Sward K., et al. Effects of oats on plasma cholesterol and lipoproteins in C57BL/6 mice are substrain specific. Br J Nutr 2001, 103:513-521.
13. Lichtman A.H., Clinton S.K., Iiyama K., et al. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 1999, 19:1938-1944.
14. Malkki Y., Torronen R., Pelkonen K., et al. Effects of oat-bran concentrate on rat serum lipids and liver fat infiltration. Br J Nutr 1993, 70:767-776.
15. Chait A.H.Y., Oram J.F., Heinecke J.W. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?. J Lipid Res 2005, 46:389-403.
16. Lewis K.E., Kirk E.A., McDonald T.O., et al. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation 2004, 110:540-545.
17. Dupasquier C.M., Dibrov E., Kneesh A.L., et al. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 2007, 293:H2394-H2402.
18. Lopez-Garcia E., Schulze M.B., Fung T.T., et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004, 80:1029-1035.
19. Erkkila A.T., Herrington D.M., Mozaffarian D., Lichtenstein A.H. Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J 2005, 150:94-101.
20. Theuwissen E., Mensink R.P. Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 2007, 137:583-588.
21. Theuwissen E., Plat J., Mensink R.P. Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol Nutr Food Res 2009, 53:370-376.
22. Murphy N., Grimsditch D.C., Vidgeon-Hart M., et al. Dietary antioxidants decrease serum soluble adhesion molecule (sVCAM-1, sICAM-1) but not chemokine (JE/MCP-1, KC) concentrations, and reduce atherosclerosis in C57BL but not apoE*3 Leiden mice fed an atherogenic diet. Dis Markers 2005, 21:181-190.
23. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
24. Kuhlencordt P.J., Gyurko R., Han F., et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104:448-454.
25. Cyrus T., Yao Y., Rokach J., Tang L.X., Pratico D. Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 2003, 107:521-523.
26. Lund E.K., Gee J.M., Brown J.C., Wood P.J., Johnson I.T. Effect of oat gum on the physical properties of the gastrointestinal contents and on the uptake of d-galactose and cholesterol by rat small intestine in vitro. Br J Nutr 1989, 62:91-101.
27. Theuwissen E., Mensink R.P. Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 2008, 94:285-292.
28. Lia A., Hallmans G., Sandberg A.S., et al. Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 1995, 62:1245-1251.
29. Zhang J.X., Hallmans G., Andersson H., et al. Effect of oat bran on plasma cholesterol and bile acid excretion in nine subjects with ileostomies. Am J Clin Nutr 1992, 56:99-105.
30. Kawakami A., Yoshida M. Remnant lipoproteins and atherogenesis. J Atheroscler Thromb 2005, 12:73-76.
31. Kypreos K.E., Zannis V.I. LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice. J Lipid Res 2006, 47:521-529.